Literature DB >> 946598

Interactions with the absorption of tetracyclines.

P J Neuvonen.   

Abstract

All tetracycline derivatives are bacteriostatics and their concentration in serum should not fall during the therapy below the generally accepted minimum therapeutic concentration of 0.5 to 1.5 mug/ml. Tetracyclines have a high affinity to form chelates with polyvalent metallic cations such as Fe+++, Fe++, Al+++, Mg++ and Ca++. Many of these tetracycline-metal complexes are either insoluble or otherwise poorly absorbable from the gastro-intestinal tract. Milk and other dairy products, antacids containing polyvalent cations, as well as various iron salts ingested simultaneously with tetracycline derivatives, might interfere with their absorption by 50 to 90% or even more. The severity of interaction depends both on the nature of the tetracycline derivative and of the cation, on the doses used, on pharmaceutical factors, and on time schedules in dosing. An interval of 3 hours between the ingestion of tetracyclines and cations prevents the interaction. The pharmacokinetic interactions in absorption of tetracyclines likely to be clinically significant in cases where the infecting pathogens are moderately resistant to tetracyclines and relatively high serum concentrations are needed for proper bacteriostasis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 946598     DOI: 10.2165/00003495-197611010-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  31 in total

Review 1.  Antibacterial drugs today. I.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Mediation of divalent metal ions in the binding of tetracycline to macromolecules.

Authors:  K W KOHN
Journal:  Nature       Date:  1961-09-16       Impact factor: 49.962

3.  Absorption of tetracycline in human beings as affected by certain exciplents.

Authors:  W M SWEENEY; S M HARDY; A C DORNBUSH; J M RUEGSEGGER
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1957-10

4.  Avidity of terramycin and aureomycin for metallic cations.

Authors:  A ALBERT
Journal:  Nature       Date:  1953-08-01       Impact factor: 49.962

5.  Inhibition of iron absorption by tetracycline.

Authors:  P J Neuvonen; P J Pentikäinen; G Gothoni
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

6.  Reduced absorption of aureomycin caused by aluminum hydroxide gel.

Authors:  B A WAISBREN; J S HUECKEL
Journal:  Proc Soc Exp Biol Med       Date:  1950-01

Review 7.  Effects of antibiotics and other agents on the intestinal transport of iron.

Authors:  N J Greenberger
Journal:  Am J Clin Nutr       Date:  1973-01       Impact factor: 7.045

8.  Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro.

Authors:  N H Steigbigel; C W Reed; M Finland
Journal:  Am J Med Sci       Date:  1968-03       Impact factor: 2.378

9.  Comparison of in vitro activity and clinical pharmacology of doxycycline with other tetracyclines.

Authors:  J E Rosenblatt; J E Barrett; J L Brodie; W M Kirby
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966

10.  Absorption of antibiotics: influence of metoclopramide and atropine on serum levels of pivampicillin and tetracycline.

Authors:  G Gothoni; P Pentikäinen; H I Vapaatalo; R Hackman; K af Björksten
Journal:  Ann Clin Res       Date:  1972-08
View more
  43 in total

1.  Compensation of dietary induced reduction of tetracycline absorption by simultaneous administration of EDTA.

Authors:  H Poiger; C Schlatter
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

2.  Interaction of cations and chelators with the intestinal absorption of tetracycline.

Authors:  H Poiger; C Schlatter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

Review 3.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Influence of dietary substances on intestinal drug metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Curr Drug Metab       Date:  2010-11       Impact factor: 3.731

5.  Inhibition of norfloxacin absorption by dairy products.

Authors:  K T Kivistö; P Ojala-Karlsson; P J Neuvonen
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

6.  Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.

Authors:  Gabriela Grunder; Yvonne Zysset-Aschmann; Florence Vollenweider; Thomas Maier; Stephan Krähenbühl; Juergen Drewe
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

Review 7.  Susceptibility to adverse drug reactions.

Authors:  Robin Ferner; Jeffrey Aronson
Journal:  Br J Clin Pharmacol       Date:  2019-07-17       Impact factor: 4.335

Review 8.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

9.  The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism.

Authors:  S Gilbertson-Beadling; E A Powers; M Stamp-Cole; P S Scott; T L Wallace; J Copeland; G Petzold; M Mitchell; S Ledbetter; R Poorman
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 10.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.